Filtros de búsqueda

Lista de obras de Joseph M Connors

A Canadian evidence-based guideline for the first-line treatment of follicular lymphoma: joint consensus of the Lymphoma Canada Scientific Advisory Board

artículo científico

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

article

A literature review of single agent treatment of multiply relapsed aggressive non-Hodgkin's lymphoma.

artículo científico publicado en 2002

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2012

A systematic evaluation of the ataxia telangiectasia mutated gene does not show an association with non-Hodgkin lymphoma

artículo científico publicado en 2007

ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?

artículo científico publicado en 2005

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

artículo científico publicado en 2008

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

artículo científico publicado en 2016

Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.

artículo científico publicado en 2010

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

artículo científico publicado en 2014

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis

artículo científico publicado en 2014

Alemtuzumab in clinical practice: a British Columbia experience

artículo científico publicado en 2008

Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort

artículo científico publicado en 2012

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.

artículo científico publicado en 2005

An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup

artículo científico publicado en 2014

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

artículo científico publicado en 2013

Analysis of FOXO1 mutations in diffuse large B-cell lymphoma

artículo científico publicado en 2013

Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

artículo científico publicado en 2015

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

artículo científico publicado en 2005

Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.

artículo científico publicado en 2018

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

artículo científico publicado en 2013

Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma

artículo científico publicado en 2012

B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphoma

artículo científico publicado en 2012

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

artículo científico publicado en 2006

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

artículo científico publicado en 2011

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2004

Birth order, sibship size, childhood environment and immune-related disorders and risk of lymphoma in lymphoid cancer families

artículo científico publicado en 2020

Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma

scientific article published on 07 January 2019

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study

artículo científico publicado en 2012

Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma.

artículo científico publicado en 2016

Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study

artículo científico publicado en 2013

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation

scientific article published on 06 October 2019

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency.

artículo científico publicado en 2002

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

artículo científico publicado en 2012

CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure

artículo científico publicado en 2009

CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma

artículo científico publicado en 2007

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

artículo científico publicado en 2016

CRIS: complete reconstruction of immunoglobulin <i>V-D-J</i> sequences from RNA-seq data

artículo científico publicado en 2021

Cell of origin of transformed follicular lymphoma

artículo científico publicado en 2015

Challenging problems: coincident pregnancy, HIV infection, and older age.

artículo científico publicado en 2008

Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis

artículo científico

Chemotherapy only in early stage Hodgkin lymphoma: more relapses but the same survival--what to do?

artículo científico publicado en 2014

Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada

artículo científico publicado en 2017

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

artículo científico publicado en 2010

Circos: an information aesthetic for comparative genomics

artículo científico publicado en 2009

Clinical challenges in Hodgkin lymphoma: an historical perspective.

artículo científico publicado en 2008

Clinical impact of pathology reviews of outside material: a patient-focused approach

artículo científico publicado en 2011

Clinical manifestations and natural history of Hodgkin's lymphoma

artículo científico publicado en 2009

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

artículo científico publicado en 2016

Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphoma

artículo científico publicado en 2013

Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients

artículo científico publicado en 2015

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

artículo científico publicado en 2012

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

artículo científico publicado en 2004

Contributors

Cooperative epigenetic modulation by cancer amplicon genes

artículo científico publicado en 2010

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.

artículo científico publicado en 2009

Cost-effectiveness of rituximab in follicular lymphoma

artículo científico

Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada

artículo científico publicado en 2010

Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases

artículo científico publicado en 2002

Cytogenetic findings in reactive lymphoid hyperplasia: significance of non-clonal t(3;14) and t(3;22)

scientific article published on 01 June 2002

De novo transcriptome assembly with ABySS.

artículo científico publicado en 2009

Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21.

artículo científico publicado en 2004

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

artículo científico publicado en 2014

Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection

artículo científico publicado en 2015

Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop Criteria

artículo científico publicado en 2007

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

artículo científico publicado en 2015

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

artículo científico publicado en 2005

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

artículo científico publicado en 2011

Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.

artículo científico publicado en 2016

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

artículo científico publicado en 2008

Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

artículo científico publicado en 2014

Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia

artículo científico publicado en 2014

Elevated circulating t(14;18) translocation levels prior to diagnosis of follicular lymphoma.

artículo científico publicado en 2010

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

artículo científico publicado en 2011

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms

artículo científico publicado en 2014

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project

artículo científico publicado en 2014

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia

artículo científico

Evolving approaches to primary treatment of Hodgkin lymphoma

artículo científico publicado en 2005

Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.

artículo científico publicado en 2018

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2005

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.

artículo científico publicado en 2017

Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma

artículo científico publicado en 2014

Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma

artículo científico publicado en 2017

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

artículo científico publicado en 2017

Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma

artículo científico publicado en 2016

Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group

artículo científico publicado en 2003

Fludarabine and rituximab for relapsed or refractory hairy cell leukemia

artículo científico publicado en 2012

Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes

artículo científico publicado en 2003

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

artículo científico publicado en 2011

Frequent occurrence of deletions in primary mediastinal B-cell lymphoma

article

GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study

artículo científico publicado en 2010

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.

artículo científico publicado en 2016

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

artículo científico publicado en 2008

Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma

artículo científico publicado en 2012

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

artículo científico publicado en 2014

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma

artículo científico publicado en 2012

Genetic polymorphism at BCL2 as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2017

Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.

artículo científico publicado en 2017

Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma

scientific article published on 01 June 2007

Genetic variation in cell death genes and risk of non-Hodgkin lymphoma

artículo científico publicado en 2012

Genetic variation in healthy oldest-old

artículo científico publicado en 2009

Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma

artículo científico publicado en 2009

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2018

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

artículo científico publicado en 2013

Genome-wide discovery of somatic coding and regulatory variants in Diffuse Large B-cell Lymphoma

Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances.

artículo científico publicado en 2008

Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE).

artículo científico publicado en 2013

HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen

scientific article published on 01 March 2007

Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma.

artículo científico publicado en 2006

Hand-assisted laparoscopic splenectomy versus open splenectomy for massive splenomegaly: 20-year experience at a Canadian centre

artículo científico publicado en 2011

Hepatic dysfunction during and after lymphoma chemotherapy in patients with hepatitis C.

artículo científico publicado en 2006

Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada

artículo científico publicado en 2008

High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.

artículo científico publicado en 2018

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

artículo científico publicado en 2011

High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes

article

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

scientific article published on 03 May 2005

High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologo

artículo científico publicado en 2005

High-resolution architecture and partner genes of rearrangements in lymphoma with DLBCL morphology

artículo científico

Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study

artículo científico publicado en 2016

Hodgkin lymphoma in pregnancy

artículo científico publicado en 2013

Hodgkin lymphoma in the elderly, pregnant, and HIV-infected

artículo científico publicado en 2016

Hodgkin lymphoma, treatment and thrombosis: a dangerous mix

artículo científico publicado en 2019

Hodgkin's lymphoma in adolescents

scientific article published on 01 June 2006

Hodgkin's lymphoma--the great teacher

artículo científico publicado en 2011

Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease

artículo científico publicado en 2003

Hodgkin's lymphoma: the hazards of success

scientific article published on 04 August 2003

How is Hodgkin lymphoma in pregnancy best treated? ASH evidence-based review 2008.

artículo científico publicado en 2008

I. Hodgkin lymphoma: special challenges and solutions

artículo científico

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

artículo científico publicado en 2015

Identification of a novel non-immunoglobulin/MYC translocation t(8;12)(q24;p12) involving the LRMP gene in a primary B-cell lymphoma. A case report

scientific article published on 11 October 2011

Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas

artículo científico publicado en 2004

Immune Checkpoint Inhibition: A New Era in Lymphoma Treatment

artículo científico publicado en 2016

Immunogenicity of recurrent mutations in MYD88 and EZH2 in non-Hodgkin lymphomas.

artículo científico publicado en 2015

Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP ⬇️

artículo científico publicado el 7 de marzo de 2011

Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2015

Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma

artículo científico publicado en 2015

Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada

artículo científico publicado en 2017

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

artículo científico publicado en 2015

Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma

artículo científico publicado en 2009

Interim PET-directed therapy in limited stage Hodgkin lymphoma initially treated with ABVD

scholarly article by Diego Villa et al published 12 July 2018 in Haematologica

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma

artículo científico publicado en 2017

International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.

artículo científico publicado en 2012

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

artículo científico publicado en 2005

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size

artículo científico publicado en 2008

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

artículo científico publicado en 2007

Letter comments on a published article in the New England Journal of Medicine

artículo científico publicado en 2018

Lifetime physical activity and the risk of non-Hodgkin lymphoma

artículo científico publicado en 2015

Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy

artículo científico publicado en 2012

Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation

artículo científico publicado en 2004

Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy

artículo científico publicado en 2010

Lymphoma of the skin

artículo científico publicado en 2002

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

scientific article published on 13 July 2009

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

artículo científico publicado en 2011

Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas

artículo científico publicado en 2016

Mantle cell lymphoma in the ocular adnexal region

artículo científico publicado en 2005

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop

artículo científico publicado en 2010

Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma

artículo científico publicado en 2017

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

artículo científico publicado en 2016

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

scientific article published on 31 January 2019

Molecular diagnosis of Burkitt's lymphoma

artículo científico publicado en 2006

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

artículo científico publicado en 2003

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment

artículo científico publicado en 2011

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

artículo científico publicado en 2008

More is not necessarily better when treating Hodgkin's lymphoma

artículo científico publicado en 2011

Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome

artículo científico publicado en 2003

Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing

scientific article published on 22 May 2013

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

artículo científico

New strategies for the treatment of early stages of Hodgkin's lymphoma

artículo científico publicado en 2007

Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development

artículo científico publicado en 2013

Non-Hodgkin lymphoma: the clinician's perspective--a view from the receiving end.

artículo científico

Nonrandom occurrence of lymphoid cancer types in 140 families

artículo científico publicado en 2017

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)

scientific article published on 06 December 2010

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

artículo científico publicado en 2008

Oncogenically active MYD88 mutations in human lymphoma

artículo científico publicado en 2011

Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials

artículo científico publicado en 2011

Organochlorines and risk of non-Hodgkin lymphoma

artículo científico publicado en 2007

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation

artículo científico

Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience

artículo científico publicado en 2016

Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.

artículo científico publicado en 2015

Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.

artículo científico publicado en 2015

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

artículo científico publicado en 2008

Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases

artículo científico publicado en 2017

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

artículo científico publicado en 2007

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

artículo científico publicado en 2008

Positron emission tomography in the management of Hodgkin lymphoma

artículo científico

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group

artículo científico publicado en 2005

Primary adrenal lymphoma.

artículo científico publicado en 2003

Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis

artículo científico publicado en 2005

Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival

scientific article published on 01 November 2011

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

artículo científico publicado en 2017

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

artículo científico publicado en 2015

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud

artículo científico publicado en 2014

Prognostic factors in follicular lymphoma.

scientific article published on 12 April 2010

Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone ⬇️

artículo científico publicado el 1 de septiembre de 2010

Prognostic significance of secondary cytogenetic alterations in follicular lymphomas.

artículo científico publicado en 2008

Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis.

artículo científico publicado en 2016

Radioimmunotherapy--hot new treatment for lymphoma

artículo científico publicado en 2005

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial

artículo científico publicado en 2003

Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

artículo científico publicado en 2005

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

artículo científico publicado en 2012

Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting

artículo científico publicado en 2007

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

artículo científico publicado en 2014

Recurrent targets of aberrant somatic hypermutation in lymphoma

artículo científico publicado en 2012

Reduced telomere length variation in healthy oldest old.

artículo científico publicado en 2008

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma

artículo científico publicado en 2020

Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting

artículo científico publicado en 2016

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma

artículo científico publicado en 2012

Revised response criteria for malignant lymphoma

artículo científico publicado en 2007

Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma

artículo científico publicado en 2015

Rituximab with high-dose methotrexate in primary central nervous system lymphoma

scientific article published on 17 November 2015

Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma

artículo científico publicado en 2016

Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma

artículo científico publicado en 2013

Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model.

artículo científico publicado en 2016

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

artículo científico publicado en 2010

State-of-the-art therapeutics: Hodgkin's lymphoma

artículo científico publicado en 2005

Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors

artículo científico publicado en 2013

TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma

artículo científico publicado en 2012

Tattoos and hematological malignancies in British Columbia, Canada

artículo científico publicado en 2020

The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.

artículo científico publicado en 2013

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.

artículo científico publicado en 2015

The Super-Seniors Study: Phenotypic characterization of a healthy 85+ population.

artículo científico publicado en 2018

The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation

artículo científico publicado en 2009

The case for chemotherapy alone for limited-stage Hodgkin's lymphoma

artículo científico publicado en 2012

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

artículo científico publicado en 2013

The important role of secondary treatment in Hodgkin lymphoma

artículo científico publicado en 2012

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

artículo científico publicado en 2007

The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases

artículo científico publicado en 2004

The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency

artículo científico publicado en 2005

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

artículo científico publicado en 2002

To treat or not to treat, that is the NLPHL question

artículo científico publicado en 2019

Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells

artículo científico publicado en 2015

Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma

artículo científico publicado en 2010

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

artículo científico publicado en 2011

Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience

artículo científico

Treatment and outcomes of primary breast lymphoma

artículo científico publicado en 2012

Treatment of NLPHL.

artículo científico publicado en 2013

Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.

artículo científico publicado en 2005

Treatment of diffuse large B-cell lymphoma: a risk-based approach.

artículo científico publicado en 2006

Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study

artículo científico publicado en 2002

Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study

artículo científico publicado en 2017

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.

artículo científico publicado en 2018

Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients

artículo científico publicado en 2003

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

artículo científico publicado en 2010

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

artículo científico publicado en 2012

Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.

artículo científico publicado en 2005

Who should-or should not-receive RT for DLBCL?

artículo científico publicado en 2014

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda